Medicare Enrolled
Dr. Ravindra Kolaventy, MD
Cardiovascular Disease · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kolaventy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kolaventy? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kolaventy
Dr. Ravindra Kolaventy is a cardiovascular disease in Ocala, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kolaventy performed 10,826 Medicare services across 2,737 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kolaventy received a total of $4,438 from 33 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kolaventy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 6% volume in FL$ $4,438 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,826
Medicare services
Top 6% in FL for cardiovascular disease
2,737
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~570 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 6,034 | $0 | $1 |
| Office visit, established patient (30-39 min) | 793 | $90 | $305 |
| Blood draw (venipuncture) | 373 | $8 | $25 |
| External counterpulsation, per treatment session | 318 | $78 | $350 |
| Comprehensive metabolic blood panel | 227 | $10 | $183 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 196 | $9 | $16 |
| Lipid panel (cholesterol and triglycerides) | 178 | $13 | $133 |
| Thyroid stimulating hormone (TSH) test | 156 | $16 | $109 |
| Vitamin B-12 level test | 151 | $15 | $131 |
| Complete blood count (CBC), automated | 137 | $6 | $133 |
| Folic acid level test | 126 | $14 | $129 |
| Free thyroxine (T4) test | 124 | $9 | $75 |
| Electrocardiogram (EKG), 12-lead | 116 | $10 | $45 |
| Hemoglobin A1c test (diabetes monitoring) | 111 | $10 | $126 |
| Echocardiogram, transthoracic | 107 | $138 | $300 |
| Complete blood count (CBC) with differential | 101 | $8 | $134 |
| Office visit, established patient, complex (40-54 min) | 85 | $116 | $339 |
| Prothrombin time test (blood clotting) | 78 | $4 | $25 |
| Drug injection, under skin or into muscle | 77 | $10 | $31 |
| Natriuretic peptide (heart and blood vessel protein) level | 73 | $38 | $138 |
| Injection, fentanyl citrate, 0.1 mg | 73 | $1 | $25 |
| Ultrasound of leg arteries or artery grafts | 69 | $178 | $372 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 68 | $38 | $96 |
| Injection of additional new drug or substance into vein | 67 | $12 | $31 |
| Injection, midazolam hydrochloride, per 1 mg | 67 | $0 | $25 |
| Injection of drug or substance into vein | 66 | $28 | $69 |
| Dihydroxyvitamin d, 1, 25 level | 62 | $38 | $111 |
| Ultrasound of both sides of head and neck blood flow | 57 | $131 | $293 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 56 | $14 | $85 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 56 | $1 | $25 |
| Ultrasonic guidance for blood vessel access | 51 | $30 | $57 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 44 | $13 | $110 |
| Infusion into a vein for hydration, 31-60 minutes | 40 | $25 | $53 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 32 | $334 | $1,326 |
| Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | 32 | $617 | $2,750 |
| New patient office visit (45-59 min) | 30 | $115 | $382 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 29 | $979 | $2,285 |
| Initial hospital admission, high complexity | 25 | $133 | $450 |
| Removal of plaque in artery of leg, each additional vessel | 24 | $810 | $1,775 |
| Office visit, established patient (20-29 min) | 24 | $67 | $212 |
| Testosterone (hormone) level, total | 23 | $25 | $132 |
| Vitamin D level test | 22 | $29 | $161 |
| PSA test (prostate cancer screening) | 20 | $18 | $130 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 20 | $20 | $49 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 20 | $617 | $1,013 |
| Removal of plaque in artery of leg, initial vessel | 19 | $6,411 | $15,641 |
| Testosterone (hormone) level, free | 18 | $25 | $138 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $41 | $94 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 17 | $125 | $287 |
| Review by radiologist of arm or leg artery image | 16 | $118 | $240 |
| Transitional care management services for problem of high complexity | 16 | $214 | $415 |
| Thyroid hormone, t3 measurement, free | 15 | $17 | $150 |
| Flu vaccine administration | 15 | $30 | $117 |
| C-reactive protein test (inflammation marker) | 14 | $5 | $145 |
| Flu vaccine, quadrivalent | 14 | $76 | $130 |
| Transitional care management services for problem of at least moderate complexity | 14 | $136 | $310 |
| Cardiac catheterization | 13 | $401 | $1,647 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
61.1% medium
37.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,438
Total received (2018-2024)
Avg $634/year across 7 years
Top 43% in FL for cardiovascular disease
33
Companies
108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,438 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$195
2023$314
2022$439
2021$425
2020$464
2019$553
2018$2,046
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Philips Electronics North America Corporation
$1,047
Medtronic Vascular, Inc.
$671
AstraZeneca Pharmaceuticals LP
$511
Novartis Pharmaceuticals Corporation
$414
Amgen Inc.
$391
Janssen Pharmaceuticals, Inc
$326
Impulse Dynamics (USA) Inc.
$274
Novo Nordisk Inc
$114
Ipsen Biopharmaceuticals, Inc
$83
Boston Scientific Corporation
$59
Alnylam Pharmaceuticals Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Bardy Diagnostics, Inc.
$42
PFIZER INC.
$41
Edwards Lifesciences Corporation
$41
Bard Peripheral Vascular, Inc.
$31
Lundbeck LLC
$29
ORGANOGENESIS INC.
$25
Merck Sharp & Dohme LLC
$24
United Therapeutics Corporation
$22
Watermark Medical, Inc.
$21
BOSTON SCIENTIFIC CORPORATION
$18
Merck Sharp & Dohme Corporation
$17
Medtronic, Inc.
$16
Abbott Laboratories
$15
E.R. Squibb & Sons, L.L.C.
$13
iRhythm Technologies, Inc.
$13
Tactile Systems Technology Inc
$12
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$12
Alexion Pharmaceuticals, Inc.
$12
MEDICOMP INC
$12
Amarin Pharma Inc.
$12
Braemar Manufacturing, LLC
$11
Top 3 companies account for 50.2% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · AMBULATORY CARDIAC MONITOR · BRILINTA · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Claria MRI · Corlanor · ELIQUIS · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · FARXIGA · Flexitouch Plus · HawkOne · IGT D Peripheral · IN.PACT Admiral · IVUS Systems · Image Guided Therapy Devices _ Peripheral · JARDIANCE · JOT DX · LEQVIO · LUX DX · LifeVest · NORTHERA · ONPATTRO · OPTIMIZER · ORENITRAM · Onivyde · Optimizer · Ozempic · Puraply Antimicrobial · Repatha · SAPIEN 3 Ultra RESILIA · Soliris · Turbo Elite · VERQUVO · VYNDAMAX · Vascepa · Venclose Maven Catheter · Visions PV .035 · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $41 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
53
Per 100K population
13.7
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kolaventy is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kolaventy experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kolaventy performed 6,034 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kolaventy receive payments from pharmaceutical companies?
Yes. Dr. Kolaventy received a total of $4,438 from 33 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kolaventy's costs compare to other cardiovascular diseases in Ocala?
Dr. Kolaventy's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kolaventy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Ocala
Browse cardiovascular diseases in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology